May 16th, 2013
Evotec and Harvard University to collaborate on development of new class of antibacterials
Target PGB (PEPTIDOGLYCAN BIOSYNTHESIS) is the focus of collaboration designed to develop novel family of antibacterial drugs based on highly validated target